Publication Name	World Journal of Virology
Manuscript ID	76352
Country	India

Received	2022-03-13 10:04
Peer-Review Started	2022-03-13 10:06
To Make the First Decision
Return for Revision	2022-04-13 11:41
Revised	2022-04-25 11:00
Second Decision	2022-06-17 03:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-06-20 17:34
Articles in Press	2022-06-20 17:34
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-07-25 09:06
Typeset the Manuscript	2022-09-16 05:50
Publish the Manuscript Online	2022-09-24 10:56

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Virology
Manuscript Type	Review
Article Title	Association of COVID-19 with hepatic metabolic dysfunction
Manuscript Source	Invited Manuscript
All Author List	Ramesh Kumar, Vijay Kumar, Rahul Arya, Utpal Anand and Rajeev Nayan Priyadarshi
Funding Agency and Grant Number
Corresponding Author	Ramesh Kumar, MD, Associate Professor, Department of Gastroenterology, All India Institute of Medical Sciences, Patna, Phulwari Sharif, Patna 801507, Bihar, India. docrameshkr@gmail.com
Key Words	COVID-19; Coronavirus; Metabolism; Metabolic syndrome; Metabolic inflammation; Hepatic dysfunction
Core Tip	In coronavirus disease 2019 (COVID-19) patients, the virus induces a complex viral-host interaction that leads to metabolic reprogramming, altered immunological responses, and a variety of clinical consequences. In metabolomic and lipidomic studies, a variety of alterations in amino acids, lipids, carbohydrates, and energy metabolism have been identified in such patients. The liver is the primary metabolic organ; thus, these metabolic alterations may have a major impact on patients with liver diseases and metabolic comorbidities that are common in COVID-19 patients. Therefore, this review article discusses the pathophysiological aspects and clinical implications of metabolic dysfunction in COVID-19 patients with a focus on the liver.
Publish Date	2022-09-24 10:56
Citation	Kumar R, Kumar V, Arya R, Anand U, Priyadarshi RN. Association of COVID-19 with Hepatic Metabolic Dysfunction. World J Virol 2022; 11(5): 237-251
URL	https://www.wjgnet.com/2220-3249/full/v11/i5/237.htm
DOI	https://dx.doi.org/10.5501/wjv.v11.i5.237

Full Article (PDF)	WJV-11-237.pdf
Full Article (Word)	WJV-11-237.docx
Manuscript File	76352_Auto_Edited_LM-Language editing-Webster J-Clear.docx
Answering Reviewers	76352-Answering reviewers.pdf
Audio Core Tip	76352-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	76352-Conflict-of-interest statement.pdf
Copyright License Agreement	76352-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	76352-Language certificate.pdf
Peer-review Report	76352-Peer-review(s).pdf
Scientific Misconduct Check	76352-Bing-Liu JH-2.jpg
Scientific Misconduct Check	76352-CrossCheck.jpg
Scientific Editor Work List	76352-Scientific editor work list.pdf